{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:17:29Z","timestamp":1786997849703,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.urology.2025.02.041","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T03:02:54Z","timestamp":1741057374000},"page":"112-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Financial Toxicity in Spina Bifida: Development of a Patient and Caregiver Questionnaire"],"prefix":"10.1016","volume":"199","author":[{"given":"Diana A.","family":"Aponte-Colon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael D.","family":"Tua-Caraccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid I.","family":"Aksenov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Thibadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7731-963X","authenticated-orcid":false,"given":"Jonathan C.","family":"Routh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce B.","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4 Pt 2","key":"10.1016\/j.urology.2025.02.041_bib1","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.juro.2015.11.033","article-title":"Nationwide trends and variations in urological surgical interventions and renal outcome in patients with spina bifida","volume":"195","author":"Wang","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.02.041_bib2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.juro.2014.06.085","article-title":"Emergent care patterns in patients with spina bifida: a case-control study","volume":"193","author":"Wang","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2025.02.041_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40120-013-0007-0","article-title":"A review of the social, psychological, and economic burdens experienced by people with spina bifida and their caregivers","volume":"2","author":"Rofail","year":"2013","journal-title":"Neurol Ther"},{"key":"10.1016\/j.urology.2025.02.041_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/bdra.20360","article-title":"Health care expenditures of children and adults with spina bifida in a privately insured U.S. population","volume":"79","author":"Ouyang","year":"2007","journal-title":"Birth Defects Res Clin Mol Teratol"},{"key":"10.1016\/j.urology.2025.02.041_bib5","series-title":"Neural Tube Defects: From Origin to Treatment","first-page":"342","article-title":"The half-life of cost-of-illness estimates: the case of spina bifida","author":"Waitzman","year":"2005"},{"key":"10.1016\/j.urology.2025.02.041_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.dhjo.2019.01.007","article-title":"Hospital and ED charges for spina bifida care in the United States between 2006 and 2014: over $2 billion annually","volume":"12","author":"Inouye","year":"2019","journal-title":"Disabil Health J"},{"key":"10.1016\/j.urology.2025.02.041_bib7","first-page":"1357","article-title":"Financial toxicity and symptom burden: what is the big deal?","volume":"26","author":"Chan","year":"2018","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"10.1016\/j.urology.2025.02.041_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jamaoncol.2016.4850","article-title":"Mitigating financial toxicity among US patients with cancer","volume":"3","author":"de Souza","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urology.2025.02.041_bib9","doi-asserted-by":"crossref","first-page":"290.e1","DOI":"10.1016\/j.jpurol.2022.03.002","article-title":"Financial toxicity among individuals with spina bifida and their families: a qualitative study and conceptual model","volume":"18","author":"Aksenov","year":"2022","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.urology.2025.02.041_bib10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2025.02.041_bib11","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/cncr.28814","article-title":"The development of a financial toxicity patient-reported outcome in cancer: the COST measure","volume":"120","author":"de Souza","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2025.02.041_bib12","series-title":"Testing Structural Equation Models","first-page":"136","article-title":"Alternative ways of assessing model fit","author":"Browne","year":"1993"},{"key":"10.1016\/j.urology.2025.02.041_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02291170","article-title":"A reliability coefficient for maximum likelihood factor analysis","volume":"38","author":"Tucker","year":"1973","journal-title":"Psychometrika"},{"key":"10.1016\/j.urology.2025.02.041_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1037\/0033-2909.107.2.238","article-title":"Comparative fit indexes in structural models","volume":"107","author":"Bentler","year":"1990","journal-title":"Psychol Bull"},{"key":"10.1016\/j.urology.2025.02.041_bib15","series-title":"Structural Equation Modeling: Concepts, Issues, and Applications","first-page":"76","article-title":"Evaluating model fit","author":"Hu","year":"1995"},{"key":"10.1016\/j.urology.2025.02.041_bib16","series-title":"Mplus User\u2019s Guide","author":"Muth\u00e9n","year":"1998"},{"key":"10.1016\/j.urology.2025.02.041_bib17","first-page":"1889","article-title":"ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research","volume":"22","author":"Reeve","year":"2013","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"key":"10.1016\/j.urology.2025.02.041_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30685","article-title":"Designing and validating novel communication measures for pediatric, adolescent, and young adult oncology care and research: the PedCOM measures","volume":"70","author":"Sisk","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.urology.2025.02.041_bib19","unstructured":"Graph Pad \u3008https:\/\/www.graphpad.com\u3009. La Jolla, California: GraphPad Software; c2024 [updated 2024 October 20]. The Holm-\u0160\u00edd\u00e1k approach to multiple comparisons. \u3008https:\/\/www.graphpad.com\/guides\/prism\/latest\/statistics\/stat_holms_multiple_comparison_test.htm\u3009."},{"key":"10.1016\/j.urology.2025.02.041_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1200\/JCO.2015.62.0468","article-title":"Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors","volume":"34","author":"Yabroff","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.urology.2025.02.041_bib21","doi-asserted-by":"crossref","first-page":"817.e1","DOI":"10.1016\/j.ajog.2021.12.012","article-title":"Risk factors for financial toxicity in patients with gynecologic cancer","volume":"226","author":"Aviki","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.urology.2025.02.041_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ijgc-2021-002475","article-title":"Evaluating meaningful levels of financial toxicity in gynecologic cancers","volume":"31","author":"Esselen","year":"2021","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc"},{"key":"10.1016\/j.urology.2025.02.041_bib23","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1245\/s10434-024-15236-6","article-title":"Prevalence of and factors associated with financial toxicity after pancreatectomy and gastrectomy","volume":"31","author":"Hirata","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urology.2025.02.041_bib24","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1001\/jamapediatrics.2020.3973","article-title":"Changes in health care-related financial burden for US families with children associated with the affordable care act","volume":"174","author":"Wisk","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.urology.2025.02.041_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176470","article-title":"Financial distress in patients with advanced cancer","volume":"12","author":"Barbaret","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.urology.2025.02.041_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1469-8749.1986.tb03831.x","article-title":"Assessing the impact of a child with spina bifida on the family","volume":"28","author":"McCormick","year":"1986","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.urology.2025.02.041_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0272989X08322014","article-title":"Labor market productivity costs for caregivers of children with spina bifida: a population-based analysis","volume":"29","author":"Tilford","year":"2009","journal-title":"Med Decis Mak Int J Soc Med Decis Mak"},{"key":"10.1016\/j.urology.2025.02.041_bib28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JOP.2014.001542","article-title":"Population-based assessment of cancer survivors\u2019 financial burden and quality of life: a prospective cohort study","volume":"11","author":"Zafar","year":"2015","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.urology.2025.02.041_bib29","first-page":"388","article-title":"Factors associated with increased financial toxicity after the completion of radiation treatment for gynecologic cancer","volume":"31","author":"Esselen","year":"2023","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525002067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429525002067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T04:19:09Z","timestamp":1746505149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429525002067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":29,"alternative-id":["S0090429525002067"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2025.02.041","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Financial Toxicity in Spina Bifida: Development of a Patient and Caregiver Questionnaire","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2025.02.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}